2m 2m 2m 2m 2m 2m 2m
OPTION CR HEALTH (OPCH)
NASDAQ
$22.01+$0.04 (+0.16%)
Price as of Jun 23, 2026 5:42 PM EDT- $3.3BMarket Cap
- -31.40%1-Year Change
- Medical Care FacilitiesIndustry
OPTION CR HEALTH (OPCH)
$22.01+$0.04 (+0.16%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.6B +13.03% | 5.0B +16.17% | 4.3B +9.06% | 3.9B +14.72% | |
Cost of Revenue | 4.6B +14.46% | 4.0B +20.00% | 3.3B +7.90% | 3.1B +15.75% | |
Gross Profit | 1.1B +7.39% | 1.0B +3.24% | 981.2M +13.19% | 866.9M +11.20% | |
Sales and Marketing Expense | 682.5M +8.28% | 630.3M +3.76% | 607.4M +7.30% | 566.1M +7.69% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 70.7M +11.33% | 63.5M +2.09% | 62.2M -4.94% | 65.4M -4.90% | |
Total Operating Expenses | 750.0M +8.51% | 691.2M +3.68% | 666.6M +6.37% | 626.7M +6.44% | |
Operating Profit | 337.9M +4.99% | 321.8M +2.30% | 314.6M +30.96% | 240.2M +25.88% | |
Interest Income | N/A N/A | N/A N/A | 5.3M N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -51.2M -4.75% | -53.8M -19.70% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -45.9M -14.60% | -53.8M -19.70% | |
Total Nonoperating Income and Expense | -55.0M +43.87% | -38.2M -142.55% | 89.9M +532.05% | 14.2M +206.31% | |
Income before Taxes | 282.9M -0.25% | 283.6M -20.95% | 358.7M +74.34% | 205.8M +76.63% | |
Income Taxes | 75.3M +4.93% | 71.8M -21.69% | 91.7M +66.00% | 55.2M +335.91% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 207.6M -2.00% | 211.8M -20.69% | 267.1M +77.40% | 150.6M +7.62% | |
Net Income from Continuing Operations Applicable to Common | 282.9M -0.25% | 283.6M -20.95% | 358.7M +74.34% | 205.8M +76.63% | |
Basic EPS and Net Income | 1.28 +4.07% | 1.23 -17.45% | 1.49 +79.52% | 0.83 +6.41% | |
Diluted EPS and Net Income | 1.27 +3.25% | 1.23 -16.89% | 1.48 +78.31% | 0.83 +7.79% | |
Basic Weighted Average Shares | 162.1M -5.52% | 171.6M -4.14% | 179.0M -1.18% | 181.1M +0.70% | |
Diluted Weighted Average Shares | 163.4M -5.48% | 172.8M -4.17% | 180.4M -0.93% | 182.1M +0.48% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 232.6M -43.62% | 412.6M +19.98% | 343.8M +16.88% | 294.2M +146.34% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 232.6M -43.62% | 412.6M +19.98% | 343.8M +16.88% | 294.2M +146.34% | |
Total Current Assets | 1.3B -4.36% | 1.3B +20.87% | 1.1B +10.05% | 994.3M +40.00% | |
Accumulated Depreciation | 129.8M +7.69% | 120.5M -2.69% | 123.9M +1.56% | 122.0M +2.65% | |
Property and Plant and Equipment and Net | 139.2M +9.32% | 127.4M +5.58% | 120.6M +11.36% | 108.3M -2.88% | |
Total Long-Term Assets | 2.2B +4.37% | 2.1B -1.11% | 2.1B +0.20% | 2.1B +1.82% | |
Total Assets | 3.5B +0.99% | 3.4B +6.36% | 3.2B +3.34% | 3.1B +11.54% | |
Income Taxes Payable | 56.0M +17.75% | 47.6M +36.24% | 34.9M +57.62% | 22.2M N/A | |
Total Short-Term Debt | 6.8M +4.12% | 6.5M +8.53% | 6.0M 0.00% | 6.0M 0.00% | |
Total Current Liabilities | 829.3M +6.31% | 780.1M +26.17% | 618.3M +9.37% | 565.4M +22.98% | |
Total Long-Term Debt | 1.2B +4.47% | 1.1B +4.54% | 1.1B -0.15% | 1.1B -0.16% | |
Total Long-Term Liabilities | 1.3B +5.06% | 1.2B +5.12% | 1.2B +1.34% | 1.2B +0.53% | |
Total Liabilities | 2.1B +5.55% | 2.0B +12.37% | 1.8B +3.97% | 1.7B +6.92% | |
Retained Earnings | 876.9M +31.01% | 669.3M +46.30% | 457.5M +140.26% | 190.4M +377.65% | |
Total Stockholders Equity | 1.3B -5.54% | 1.4B -1.23% | 1.4B +2.57% | 1.4B +17.88% | |
Total Shares Outstanding | 156.9M -5.66% | 166.3M -4.76% | 174.6M -4.06% | 182.0M +1.13% | |
Cash Flow | |||||
Cash from Operating Activities | 258.4M -20.08% | 323.4M -12.90% | 371.3M +38.78% | 267.5M +28.28% | |
Capital Expenditures | 41.3M +16.01% | 35.6M -14.95% | 41.9M +18.41% | 35.4M +37.94% | |
Cash from Investing Activities | -161.1M +341.69% | -36.5M -35.46% | -56.5M -47.70% | -108.1M -3.13% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -277.3M +27.08% | -218.2M -17.70% | -265.1M -1,836.48% | 15.3M +119.86% | |
Financials Ratio | |||||
Gross Margin | 19.26% -4.99% | 20.27% -11.14% | 22.81% +3.78% | 21.98% -3.07% | |
Operating Margin | 5.98% -7.11% | 6.44% -11.94% | 7.31% +20.07% | 6.09% +9.73% | |
Return on Assets | 6.04% -5.40% | 6.38% -24.38% | 8.44% +65.46% | 5.10% -0.87% | |
Return on Equity | 15.20% +1.42% | 14.99% -21.20% | 19.03% +61.87% | 11.75% -7.94% | |
Revenue Growth | 13.03% -19.43% | 16.17% +78.43% | 9.07% -38.41% | 14.72% +9.93% | |
Current Ratio | 1.53 -10.03% | 1.70 -4.20% | 1.77 +0.63% | 1.76 +13.83% | |
Cash Ratio | 0.28 -46.96% | 0.53 -4.91% | 0.56 +6.86% | 0.52 +100.31% | |
Debt-to-Equity Ratio | 0.88 +10.60% | 0.79 +5.86% | 0.75 -2.64% | 0.77 -15.30% | |
Debt-to-Assets Ratio | 0.34 +3.45% | 0.32 -1.70% | 0.33 -3.39% | 0.34 -10.47% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow